ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Clinical trial NCT03594227 · COMPLETED
Trial details
- NCT number
- NCT03594227
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-11
- Primary completion
- 2019-06-06
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.